RE FRANCESCA

Renda, A., Antoniou, A., Quadri, M., Comi, S., Amenta, A., Sesana, S., et al. (2026). MMP2-Responsive Liposomes Targeting LDLR Enhance the Effectiveness of Anti-Cancer Drugs in Treating Melanoma. ADVANCED THERAPEUTICS, 9(1) [10.1002/adtp.202500257]. Dettaglio

Patrucco, M., Sica, F., Ieva, F., Mangolini, A., Picciolini, S., Sierri, G., et al. (2025). Brain Metastasis-Derived Nanoparticles: A Novel Strategy for Enhanced CNS Drug Delivery. Intervento presentato a: Next Gen3Ration Research - 18-19 September 2025, Genova, Italia. Dettaglio

Patrucco, M., Sica, F., Ieva, F., Mangolini, A., Picciolini, S., Sierri, G., et al. (2025). Brain Metastasis-Derived Nanoparticles: A Novel Strategy for Enhanced CNS Drug Delivery. Intervento presentato a: 5th Workshop SIB group “Tumor Biochemistry” Is cancer an inaccessible fortress? Exploiting tumor Achille’s heels to foster treatment opportunities. 5th Workshop of the SIB group “Tumor Biochemistry” - 9-10 June 2025, Torino, Italia. Dettaglio

Iannone, M., Kravicz, M., Rainone, P., Antoniou, A., Stucchi, S., Valtorta, S., et al. (2025). Automated fluorine-18 radiolabeling via an alkyne–azide cycloaddition reaction on a dual peptide-functionalized liposome surface for in vivo PET imaging. FRONTIERS IN PHARMACOLOGY, 16 [10.3389/fphar.2025.1566257]. Dettaglio

Amenta, A., Comi, S., Kravicz, M., Sesana, S., Antoniou, A., Passarella, D., et al. (2025). A novel, glutathione-activated prodrug of pimasertib loaded in liposomes for targeted cancer therapy. RSC MEDICINAL CHEMISTRY, 16(1), 168-178 [10.1039/d4md00517a]. Dettaglio